Literature DB >> 3958351

Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure.

M A Alpert, J J Curtis, J F Sanfelippo, G C Flaker, J T Walls, V Mukerji, D Villarreal, S K Katti, N P Madigan, R B Krol.   

Abstract

To determine whether survival after permanent ventricular demand (VVI) pacing differs from survival after permanent dual chamber (DVI or DDD) pacing in patients with chronic high degree atrioventricular (AV) block (Mobitz type II or trifascicular block), 132 patients who received a VVI pacemaker (Group 1) and 48 patients who received a DVI or DDD pacemaker (Group 2) were followed up for 1 to 5 years. There was no significant difference in sex distribution, mean age or incidence of coronary heart disease, hypertension, valvular heart disease, diabetes mellitus, stroke or renal failure between Groups 1 and 2. Overall, the predicted cumulative survival rate at 1, 3 and 5 years was 89, 76 and 73%, respectively, for Group 1 and 95, 82 and 70%, respectively, for Group 2. In patients with preexistent congestive heart failure, the predicted cumulative survival rate at 1, 3 and 5 years was 85, 66 and 47%, respectively, for Group 1 (n = 53) and 94, 81 and 69%, respectively, for Group 2 (n = 20). The 5 year predicted cumulative survival rate was significantly lower in Group 1 patients with preexistent congestive heart failure than in Group 2 patients with the same condition (p less than 0.02). There was no significant difference in 5 year cumulative survival rate between Groups 1 and 2 for patients without preexistent congestive heart failure. The results suggest that permanent dual chamber pacing enhances survival to a greater extent than does permanent ventricular demand pacing in patients with high degree AV block and preexistent congestive heart failure.

Entities:  

Mesh:

Year:  1986        PMID: 3958351     DOI: 10.1016/s0735-1097(86)80358-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Is VVI pacing outmoded?

Authors:  A W Nathan; D W Davies
Journal:  Br Heart J       Date:  1992-04

2.  Permanent pacemaker insertion in a district general hospital: indications, patient characteristics, and complications.

Authors:  A Eltrafi; P Currie; J H Silas
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

3.  Pacing mode and long-term survival in elderly patients with congestive heart failure: 1980-1985.

Authors:  P A Brady; W K Shen; S A Neubauer; S C Hammill; D O Hodge; D L Hayes
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

4.  The United Kingdom pacing and cardiovascular events (UKPACE) trial. United Kingdom Pacing and Cardiovascular Events.

Authors:  W D Toff; J D Skehan; D P De Bono; A J Camm
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

Review 5.  Recent advances in cardiology.

Authors:  C S Lawson; D J Coltart
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

6.  Cardiac pacing for bradyarrhythmias in the elderly.

Authors:  R Sutton
Journal:  J R Soc Med       Date:  1994-04       Impact factor: 5.344

7.  Issues in cardiac pacing: can agism be justified?

Authors:  G E Payne; J D Skehan
Journal:  Br Heart J       Date:  1994-08

8.  Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study.

Authors:  A V Mattioli; E T Castellani; D Vivoli; F A Sgura; G Mattioli
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

9.  A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing.

Authors:  S K Pehrsson; P Hjemdahl; R Nordlander; H Aström
Journal:  Br Heart J       Date:  1988-09

Review 10.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.